PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Lara D. Veeken4 citations

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework

View Full Paper
SBSilvia Laura BoselloAOAugusta OrtolanLLL. Lanzo

Key Points

  • This study aims to utilize AI and natural language processing to identify clinical phenotypes and track disease progression in systemic lupus erythematosus (SLE) patients.
  • Used electronic health records (EHRs) of SLE patients to extract unstructured data.
  • Developed a natural language processing (NLP) pipeline complemented by human intelligence.
  • Defined clinical domains and complexity phenotypes using ontology-based approaches.
  • Identified 262 eligible patients from 1000 extracted EHRs, with 88% female and a median age of 43 years.
  • At first contact, 43% had high complexity phenotypes, experiencing more disease flares over time.
  • Patients with low and medium complexity phenotypes saw more new clinical domains and increased medication use during follow-up.

Abstract

Abstract Objectives Electronic Health Records (EHRs) contain a wealth of unstructured patient data that can be leveraged using Artificial Intelligence (AI). This study aimed to develop a Natural Language Processing (NLP)pipeline to identify clinical phenotypes and disease trajectories in patients with Systemic Lupus Erythematosus (SLE) from EHRs. Methods EHR data from SLE patients were included. A standardized stepwise framework combining AI and human intelligence (HI) was designed. Ontology-based definitions were developed for clinical domains, flares, and disease complexity phenotypes (low, medium, high) at the first contact, and corresponding data were extracted using an NLP-based pipeline. Results Out of 1000 extracted patients, inclusion criteria were met by 262 who had≥ hospitalization, ≥1outpatient visit, and a follow-up ≥ 1.5 years. Among these, 88% were female, median age was 43 years, median follow-up 6 years. At first contact, the most frequently involved clinical domains were hematological (64%), articular (47%), cutaneous (59%), and renal (58%). At first contact, 43% of patients presented with a high-complexity phenotype, 35% medium, 22% low complexity: the first group experienced more flares over time (5 vs 3 and 3, p 0.001). Patients with a low and medium complexity phenotype showed a higher increase in new clinical domains and in the use of conventional immunosuppressants, biologics, and glucocorticoids during follow-up. Conclusions This novel framework, based on real-world data, enables longitudinal phenotype characterization of SLE patients. It demonstrates promise as a feasible tool to study the heterogeneity of SLE and its progression over time, offering insights into potential applications in clinical research and patient management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bosello et al. (2026) studied this question.

synapsesocial.com/papers/6996a8c7ecb39a600b3efd2ehttps://doi.org/10.1093/rheumatology/keag035
Ask AI
Helpful
Bookmark
Share
View Full Paper